Huw Jones

MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.

PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK.

Tri-Star Antimony Canada Inc. engages in the acquisition, exploration and development of mineral resource properties. Its projects include Golden Ridge, Golden Pike, Bald Hill, Annidale Gold Belt, Clarence Stream, Armstrong Brook Oak Bay, Mount Pleasant and Pughole-Whopper Property. The company was founded in 2006 and is headquartered in Saint John, Canada.

Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis.

RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany.

CACI Ltd. provides consumer and market analysis solutions. Its products include acorn, AnaBase, ORECASTER, ChildView, cygnum, dataACE, EMAIL STUDIO, fresco, infoflow, InSite, and InView. The firm also provides integrated marketing, location planning, technology, and network solutions. The company was founded in 1975 and is headquartered in London, the United Kingdom.

Hilti, Inc. manufactures and markets hand tools and power tools. Its products include powder-actuated fastening systems, drilling and demolition systems, diamond coring, cutting and sawing systems, cutting, sawing, grinding systems, measuring systems, cordless systems, firestop and fire protection systems, power tool consumables, screw and direct fastening systems, adhesive and mechanical anchoring systems, installation systems, strut and hanger systems and construction chemicals. The company was founded in 1941 and is headquartered in Plano, TX.

Unirac, Inc. manufactures solar racking. Its products include solar mount, sunframe, microrail, roof mount, large array, and ground fixed tilt. The company was founded by John Liebendorfer and Hal Newman in 1998 and is headquartered in Albuquerque, MN.

DBW FM LTD (Finance Wales) is a venture capital subsidiary of Development Bank of Wales Plc founded in 2000. The firm is headquartered in Cardiff, the United Kingdom.

Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. Celleron has deep relationships with Oxford University and is located on the Oxford Science Park. The British company focuses on the clinical development of new and innovative therapies to treat cancer. Celleron is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. The company's lead products are currently in clinical trials, and they have a biomarker platform that allows them to identify responsive patients. Celleron Therapeutics Ltd. was founded in 2004, and the CEO is Nick la Thangue.

ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.

Vulpes Investment Management Ltd. provides investment advice. The company was founded by Martin Diggle and is headquartered in George Town, Cayman Islands.

The Marketing Practice (UK) Ltd. provides digital media and marketing services. The company is based in London, UK. and has subsidiaries in United Kingdom, United States and Australia. The British company was founded in 2002. The CEO is Matthew David Harper.

Delin Ventures Ltd. (Delin Ventures) is a venture capital firm founded in 2013 by Igor Linshits. The firm headquartered in London, United Kingdom.

The University Commercialization Fund invests in high-tech companies located in Michigan. The fund focuses on companies operating in the fields of advanced manufacturing, alternative energy, homeland defense, information technology and life science industry. It provides financing for seed and early stage companies requirements with an investment size of up to $0.05 million.

Strategic & Precious Metals Processing LLC engages in the production of antimony metal used in lead and tin applications and antimony trioxide for the plastics flame-retardant market. Its projects include Antimony Roasting Facility located in Port of Sohar Free Zone, Sultanate of Oman. The company was founded in 2015 and is headquartered in Sohar, Oman.

Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom.

Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY.

Incendia Therapeutics, Inc. develops a novel class of anti-cancer therapies. The company is based in Boston, MA. The company was founded in 2003 by Laurent Audoly, Colin Glenn Begley, Olga Granaturova, Guy Travis Clifton. Laurent Audoly has been the CEO since 2003.